Verzenio (abemaciclib) was granted a priority review to a new drug application (NDA) to be used in combination with an aromatase inhibitor for the frontline treatment of women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic ...and more »
Two women, two very different choices about breast cancer treatment
Studies have found that long-term survival is the same for lumpectomy or mastectomy for my type of cancer. But it's possible to know too much. I've known people who had the smallest, best cancer in the world and two years later they're at stage 4. I've ...
No comments:
Post a Comment